Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Validity and reliability of extrastriatal [11C]raclopride binding quantification in the living human brain.

Svensson JE, Schain M, Plavén-Sigray P, Cervenka S, Tiger M, Nord M, Halldin C, Farde L, Lundberg J.

Neuroimage. 2019 Aug 29;202:116143. doi: 10.1016/j.neuroimage.2019.116143. [Epub ahead of print]

PMID:
31473354
2.

Effects of age, BMI and sex on the glial cell marker TSPO - a multicentre [11C]PBR28 HRRT PET study.

Tuisku J, Plavén-Sigray P, Gaiser EC, Airas L, Al-Abdulrasul H, Brück A, Carson RE, Chen MK, Cosgrove KP, Ekblad L, Esterlis I, Farde L, Forsberg A, Halldin C, Helin S, Kosek E, Lekander M, Lindgren N, Marjamäki P, Rissanen E, Sucksdorff M, Varrone A; HRRT [11C ]PBR28 study group, Collste K, Gallezot JD, Hillmer A, Huang Y, Höglund CO, Johansson J, Jucaite A, Lampa J, Nabulsi N, Pittman B, Sandiego CM, Stenkrona P, Rinne J, Matuskey D, Cervenka S.

Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2329-2338. doi: 10.1007/s00259-019-04403-7. Epub 2019 Jul 30.

3.
4.

Meta-analytic studies of the glial cell marker TSPO in psychosis - a question of apples and pears?

Plavén-Sigray P, Cervenka S.

Psychol Med. 2019 Jul;49(10):1624-1628. doi: 10.1017/S003329171800421X. Epub 2019 Feb 11. No abstract available. Erratum in: Psychol Med. 2019 Jul;49(9):1583-1584.

5.

Trait impulsivity is not related to post-commissural putamen volumes: A replication study in healthy men.

Caravaggio F, Plavén-Sigray P, Matheson GJ, Plitman E, Chakravarty MM, Borg J, Graff-Guerrero A, Cervenka S.

PLoS One. 2018 Dec 20;13(12):e0209584. doi: 10.1371/journal.pone.0209584. eCollection 2018.

6.

Accuracy and reliability of [11C]PBR28 specific binding estimated without the use of a reference region.

Plavén-Sigray P, Schain M, Zanderigo F; Karolinska [(11)C]PBR28 study group, Rabiner EA, Gunn RN, Ogden RT, Cervenka S.

Neuroimage. 2019 Mar;188:102-110. doi: 10.1016/j.neuroimage.2018.11.020. Epub 2018 Nov 27.

7.

Test-retest reliability and convergent validity of (R)-[11C]PK11195 outcome measures without arterial input function.

Plavén-Sigray P, Matheson GJ, Cselényi Z, Jucaite A, Farde L, Cervenka S.

EJNMMI Res. 2018 Nov 29;8(1):102. doi: 10.1186/s13550-018-0455-8.

8.

Simulations to benchmark time-varying connectivity methods for fMRI.

Thompson WH, Richter CG, Plavén-Sigray P, Fransson P.

PLoS Comput Biol. 2018 May 29;14(5):e1006196. doi: 10.1371/journal.pcbi.1006196. eCollection 2018 May.

9.

Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data.

Plavén-Sigray P, Matheson GJ, Collste K, Ashok AH, Coughlin JM, Howes OD, Mizrahi R, Pomper MG, Rusjan P, Veronese M, Wang Y, Cervenka S.

Biol Psychiatry. 2018 Sep 15;84(6):433-442. doi: 10.1016/j.biopsych.2018.02.1171. Epub 2018 Mar 6.

10.

Is dopamine D1 receptor availability related to social behavior? A positron emission tomography replication study.

Plavén-Sigray P, Matheson GJ, Gustavsson P, Stenkrona P, Halldin C, Farde L, Cervenka S.

PLoS One. 2018 Mar 15;13(3):e0193770. doi: 10.1371/journal.pone.0193770. eCollection 2018.

11.

Brain neuroreceptor density and personality traits: towards dimensional biomarkers for psychiatric disorders.

Farde L, Plavén-Sigray P, Borg J, Cervenka S.

Philos Trans R Soc Lond B Biol Sci. 2018 Apr 19;373(1744). pii: 20170156. doi: 10.1098/rstb.2017.0156. Review.

12.

The readability of scientific texts is decreasing over time.

Plavén-Sigray P, Matheson GJ, Schiffler BC, Thompson WH.

Elife. 2017 Sep 5;6. pii: e27725. doi: 10.7554/eLife.27725.

13.

Assessment of simplified ratio-based approaches for quantification of PET [11C]PBR28 data.

Matheson GJ, Plavén-Sigray P, Forsberg A, Varrone A, Farde L, Cervenka S.

EJNMMI Res. 2017 Dec;7(1):58. doi: 10.1186/s13550-017-0304-1. Epub 2017 Jul 21.

14.

Reliability of volumetric and surface-based normalisation and smoothing techniques for PET analysis of the cortex: A test-retest analysis using [11C]SCH-23390.

Matheson GJ, Stenkrona P, Cselényi Z, Plavén-Sigray P, Halldin C, Farde L, Cervenka S.

Neuroimage. 2017 Jul 15;155:344-353. doi: 10.1016/j.neuroimage.2017.04.031. Epub 2017 Apr 15.

15.

Extrastriatal dopamine D2-receptor availability in social anxiety disorder.

Plavén-Sigray P, Hedman E, Victorsson P, Matheson GJ, Forsberg A, Djurfeldt DR, Rück C, Halldin C, Lindefors N, Cervenka S.

Eur Neuropsychopharmacol. 2017 May;27(5):462-469. doi: 10.1016/j.euroneuro.2017.03.007. Epub 2017 Apr 2.

16.

Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [11C]PBR28.

Collste K, Plavén-Sigray P, Fatouros-Bergman H, Victorsson P, Schain M, Forsberg A, Amini N, Aeinehband S; Karolinska Schizophrenia Project (KaSP) consortium, Erhardt S, Halldin C, Flyckt L, Farde L, Cervenka S.

Mol Psychiatry. 2017 Jun;22(6):850-856. doi: 10.1038/mp.2016.247. Epub 2017 Feb 14.

PMID:
28194003
17.

Dopamine D1 receptor availability is related to social behavior: a positron emission tomography study.

Plavén-Sigray P, Gustavsson P, Farde L, Borg J, Stenkrona P, Nyberg L, Bäckman L, Cervenka S.

Neuroimage. 2014 Nov 15;102 Pt 2:590-5. doi: 10.1016/j.neuroimage.2014.08.018. Epub 2014 Aug 16.

PMID:
25134976

Supplemental Content

Loading ...
Support Center